Indonesia Awaits Assessment Results from BPOM
The vaccine has also been deemed unrelated to recent incidents in which several recipients of the vaccine in several countries suffered from post-vaccination blood clots.
/https%3A%2F%2Fkompas.id%2Fwp-content%2Fuploads%2F2021%2F03%2F20210316coke-presiden-tinjau-vaksinasi-di-ubud_1615895513.jpg){kind=logo}
President Joko Widodo monitors the implementation of the Covid-19 vaccine immunization at Puri Saren Agung Ubud, Gianyar, Bali, Tuesday (16/3/2021).
COVID-19 vaccines produced by AstraZeneca have been declared unrelated to blood clots reportedly suffered by some who received the vaccine. Regardless, Indonesia has decided to postpone mass vaccination using AstraZeneca vaccines until the Food and Drug Administration (BPOM) concludes its assessment of the vaccine.
GENEVA, TUESDAY — The World Health Organization and the European Medicines Agency (EMA) announced that the COVID-19 vaccine produced by AstraZeneca was safe to use. The vaccine has also been deemed unrelated to recent incidents in which several recipients of the vaccine in several countries suffered from post-vaccination blood clots.